bioAffinity Technologies (BIAF) Gains from Investment Securities (2021 - 2026)
bioAffinity Technologies (BIAF) reported Gains from Investment Securities of $77174.0 for Q1 2026, up 787.57% year-over-year from $8695.0 in Q1 2025, and down 97.83% quarter-over-quarter from $3.6 million in Q4 2025.
bioAffinity Technologies (BIAF) Gains from Investment Securities (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Gains from Investment Securities data on file, last reported at $77174.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $77174.0, up 787.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (up 6173.1% YoY), and the FY2025 annual result was $9055.0, down 6.16% from the prior year.
- Gains from Investment Securities eased to $77174.0 in Q1 2026 per BIAF's latest filing, from $3.6 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $3.6 million in Q4 2025 and troughed at -$252533.0 in Q4 2024.
- A 5-year average of $378584.9 and a median of $67602.5 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities jumped 27903.36% in 2023, then plunged 397.78% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $26692.0 in 2022, then surged by 217.72% to $84805.0 in 2023, then sank by 397.78% to -$252533.0 in 2024, then surged by 1509.32% to $3.6 million in 2025, then sank by 97.83% to $77174.0 in 2026.
- Business Quant data shows BIAF's Gains from Investment Securities at $77174.0 in Q1 2026, $3.6 million in Q4 2025, and $58031.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | bioAffinity Technologies | 2.04 Mn | -1.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,174.00 |
| Mar 31, 2026 | 77,174.00 |
| Dec 31, 2025 | 3.56 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 58,031.00 |
| Sep 30, 2025 | 58,031.00 |
| Jun 30, 2025 | 92,975.00 |
| Jun 30, 2025 | 92,975.00 |
| Mar 31, 2025 | 8,695.00 |
| Mar 31, 2025 | 8,695.00 |
| Dec 31, 2024 | -252,533.00 |
| Dec 31, 2024 | -252,533.00 |
| Sep 30, 2024 | 91,038.00 |
| Sep 30, 2024 | 91,038.00 |
| Jun 30, 2024 | 90,440.00 |
| Jun 30, 2024 | 90,440.00 |
| Mar 31, 2024 | 197,954.00 |
| Mar 31, 2024 | 197,954.00 |
| Dec 31, 2023 | 84,805.00 |
| Dec 31, 2023 | 84,805.00 |